LivaNova (LIVN) EBT Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.00 |
| Dec 31, 2025 | -182.00 |
| Sep 30, 2025 | 3.00 |
| Jun 30, 2025 | 10,907.00 |
| Mar 31, 2025 | -11,717.00 |
| Dec 31, 2024 | 358.00 |
| Sep 30, 2024 | 719.00 |
| Jun 30, 2024 | 1,837.00 |
| Mar 31, 2024 | 1,881.00 |
| Dec 31, 2023 | -2,971.00 |
| Sep 30, 2023 | -249.00 |
| Jun 30, 2023 | -191.00 |
| Mar 31, 2023 | 138.00 |
| Dec 31, 2022 | 4,433.00 |
| Sep 30, 2022 | -4,948.00 |
| Jun 30, 2022 | 516.00 |
| Mar 31, 2022 | 317.00 |
| Dec 31, 2021 | 1,556.00 |
| Sep 30, 2021 | 345.00 |
| Jun 30, 2021 | -852.00 |
| Mar 31, 2021 | 10,056.00 |
| Dec 31, 2020 | -10,411.00 |
| Sep 30, 2020 | 410.00 |
| Jun 30, 2020 | -941.00 |
| Mar 31, 2020 | 5,066.00 |
| Dec 31, 2019 | -6,113.00 |
| Sep 30, 2019 | 2,082.00 |
| Jun 30, 2019 | -427.00 |
| Mar 31, 2019 | 8,551.00 |
| Dec 31, 2018 | -9,078.00 |
| Sep 30, 2018 | -981.00 |
| Jun 30, 2018 | -229.00 |
| Mar 31, 2018 | 598.00 |
| Dec 31, 2017 | -884.00 |
| Sep 30, 2017 | -1,297.00 |
| Jun 30, 2017 | 1,544.00 |
| Mar 31, 2017 | 24.00 |
| Dec 31, 2016 | 4.00 |
| Sep 30, 2016 | 61.00 |
| Jun 30, 2016 | 2,559.00 |
| Oct 18, 2015 | -6,304.00 |
| Jul 24, 2015 | 96.00 |